• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术治疗后的性别相关癌症特异性生存。

Gender-dependent cancer-specific survival following radical cystectomy.

机构信息

Department of Urology, St. Elisabeth Hospital, Straubing, Germany.

出版信息

World J Urol. 2012 Oct;30(5):707-13. doi: 10.1007/s00345-011-0773-1. Epub 2011 Oct 9.

DOI:10.1007/s00345-011-0773-1
PMID:21984471
Abstract

OBJECTIVE

To assess the impact of detailed clinical and histopathological criteria on gender-dependent cancer-specific survival (CSS) in a large consecutive series of patients following radical cystectomy (RCE) for muscle-invasive bladder cancer (MIBC).

PATIENTS AND METHODS

Between 1992 and 2007, 388 men and 133 women (25.5%) underwent RCE for MIBC. A prospectively maintained database was analysed retrospectively. Uni- and multivariable Cox-regression analyses calculated the impact of detailed clinical and histopathological criteria on CSS. Median follow-up was 59 months (2-162).

RESULTS

Among clinical and histopathological parameters, only type of urinary diversion differed between men and women. In univariable analysis, CSS did not differ between genders. In multivariable Cox-regression analysis, advanced pT-stage (HR = 2.12; P < 0.001), lymphovascular invasion (LVI) (HR = 3.47; P < 0.001), time interval between diagnosis of MIBC and RCE exceeding 90 days (HR = 2.07; P < 0.001) and female gender (HR = 1.35; P = 0.048) were related to reduced CSS. In separate multivariable Cox-models for time period of surgery between 1992 an 1999 (HR = 1.52; P = 0.050), age ≤55 years (HR = 3.00; P = 0.022), presence of LVI (HR = 1.45; P = 0.031) and female gender were associated with independent reduced CSS.

CONCLUSION

Established clinical and histopathological parameters do not differ significantly between both genders in the present series. Reduced CSS in women is present in historic cohorts possibly suggesting improvement in management over the last years. In particular, female gender has a significant negative impact on CSS in patients younger of age and with positive LVI status possibly suggesting different clinical phenotypes.

摘要

目的

在一组接受根治性膀胱切除术(RCE)治疗肌层浸润性膀胱癌(MIBC)的大型连续患者中,评估详细的临床和组织病理学标准对性别依赖性癌症特异性生存(CSS)的影响。

方法

1992 年至 2007 年间,388 名男性和 133 名女性(25.5%)接受了 RCE 治疗 MIBC。回顾性分析了前瞻性维护的数据库。单变量和多变量 Cox 回归分析计算了详细的临床和组织病理学标准对 CSS 的影响。中位随访时间为 59 个月(2-162)。

结果

在临床和组织病理学参数中,只有尿路改道的类型在男性和女性之间存在差异。在单变量分析中,CSS 在性别之间没有差异。在多变量 Cox 回归分析中,高级 pT 期(HR=2.12;P<0.001)、淋巴血管侵犯(LVI)(HR=3.47;P<0.001)、MIBC 诊断和 RCE 之间的时间间隔超过 90 天(HR=2.07;P<0.001)和女性(HR=1.35;P=0.048)与 CSS 降低相关。在 1992 年至 1999 年手术时间的单独多变量 Cox 模型中(HR=1.52;P=0.050)、年龄≤55 岁(HR=3.00;P=0.022)、存在 LVI(HR=1.45;P=0.031)和女性(HR=1.35;P=0.048)与独立的 CSS 降低相关。

结论

在本系列中,现有的临床和组织病理学参数在两性之间没有显著差异。女性 CSS 降低可能表明近年来治疗方法的改善。特别是,女性性别对年轻患者和 LVI 阳性患者的 CSS 有显著的负面影响,这可能提示存在不同的临床表型。

相似文献

1
Gender-dependent cancer-specific survival following radical cystectomy.根治性膀胱切除术治疗后的性别相关癌症特异性生存。
World J Urol. 2012 Oct;30(5):707-13. doi: 10.1007/s00345-011-0773-1. Epub 2011 Oct 9.
2
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.在病理肿瘤分期 T4a 的膀胱癌患者中,根治性膀胱切除术治疗后的癌症特异性生存的性别特异性差异。
Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6.
3
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.pT4a期膀胱尿路上皮癌根治性膀胱切除术后癌症特异性生存的预测:一种临床决策工具的开发
BJU Int. 2016 Feb;117(2):272-9. doi: 10.1111/bju.12984. Epub 2015 May 24.
4
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.根治性膀胱切除术后癌症特异性生存率和围手术期死亡率的性别差异分析:一项对近2500例膀胱尿路上皮癌患者进行的大型德国多中心研究结果
Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.
5
[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].[高龄对膀胱尿路上皮癌根治性膀胱切除术后生存的影响:德国一项膀胱尿路上皮癌根治性治疗多中心研究的生存分析]
Urologe A. 2011 Jul;50(7):821-9. doi: 10.1007/s00120-011-2507-9.
6
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.在根治性膀胱切除术中,淋巴结阴性的患者中,淋巴管浸润与总生存期、特定病因生存期以及局部和远处复发独立相关。
J Clin Oncol. 2005 Sep 20;23(27):6533-9. doi: 10.1200/JCO.2005.05.516. Epub 2005 Aug 22.
7
Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.脉管浸润、输尿管再植和膀胱癌病史与盆腔淋巴结阴性的肌层浸润性膀胱癌行部分膀胱切除术的不良预后相关。
Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.
8
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
9
Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.术前慢性肾脏病可预测膀胱癌根治性切除术的肿瘤学结局。
World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.
10
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.常规术前血液参数在肌层浸润性膀胱癌中的预后价值。
BMC Urol. 2020 Mar 19;20(1):31. doi: 10.1186/s12894-020-00602-9.

引用本文的文献

1
Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis.基于病理诊断前 CT 检查的早期膀胱癌影像学特征的系统评价。
Tomography. 2023 Sep 11;9(5):1734-1744. doi: 10.3390/tomography9050138.
2
Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer.性甾体激素受体状态在尿路上皮膀胱癌中的临床及治疗意义
Indian J Urol. 2020 Jul-Sep;36(3):171-178. doi: 10.4103/iju.IJU_320_19. Epub 2020 Jul 1.
3
Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.

本文引用的文献

1
Impact of gender on bladder cancer incidence, staging, and prognosis.性别对膀胱癌发病率、分期和预后的影响。
World J Urol. 2011 Aug;29(4):457-63. doi: 10.1007/s00345-011-0709-9. Epub 2011 Jun 9.
2
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.肌层浸润性和转移性膀胱癌的治疗:EAU 指南更新。
Eur Urol. 2011 Jun;59(6):1009-18. doi: 10.1016/j.eururo.2011.03.023. Epub 2011 Mar 23.
3
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).
台湾上尿路尿路上皮癌的肿瘤学结局的性别效应。
Int Urol Nephrol. 2020 Jun;52(6):1043-1048. doi: 10.1007/s11255-020-02396-z. Epub 2020 Jan 29.
4
Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment.膀胱癌患者按性别划分的生存差异:根治性膀胱切除术应用及治疗延迟的批判性评估。
Urol Oncol. 2017 Oct;35(10):602.e1-602.e9. doi: 10.1016/j.urolonc.2017.05.022. Epub 2017 Jun 21.
5
Female with bladder cancer: what and why is there a difference?患有膀胱癌的女性:有哪些差异以及为何会有差异?
Transl Androl Urol. 2016 Oct;5(5):668-682. doi: 10.21037/tau.2016.03.22.
6
Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.膀胱癌存在性别差异吗?一项基于人群的实践与结局研究。
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):269-74. doi: 10.5489/cuaj.2927.
7
Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder.膀胱尿路上皮癌的临床、人口统计学和组织病理学预后因素
Cent European J Urol. 2015;68(1):30-6. doi: 10.5173/ceju.2015.01.465. Epub 2015 Mar 13.
8
Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.德国膀胱癌根治性膀胱切除术后的当代性别特异性结局。
Curr Urol Rep. 2014 Jun;15(6):409. doi: 10.1007/s11934-014-0409-2.
9
High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy.热休克蛋白105的高表达预示着接受根治性膀胱切除术治疗的膀胱癌患者预后良好。
Mol Clin Oncol. 2014 Jan;2(1):38-42. doi: 10.3892/mco.2013.203. Epub 2013 Oct 18.
10
The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.尿液标志物、白光膀胱镜检查和荧光膀胱镜检查在非肌层浸润性膀胱癌复发、进展及随访中的作用
World J Urol. 2014 Jun;32(3):651-9. doi: 10.1007/s00345-013-1035-1. Epub 2013 Oct 29.
膀胱癌:生存状况的种族和性别差异(1993 年至 2002 年),分期和分级(1993 年至 2007 年)。
J Urol. 2011 May;185(5):1631-6. doi: 10.1016/j.juro.2010.12.049. Epub 2011 Mar 21.
4
Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines.泌尿系统癌症诊疗路径:在系统评价和临床实践指南背景下的制定与应用。
World J Urol. 2011 Jun;29(3):291-301. doi: 10.1007/s00345-011-0660-9. Epub 2011 Feb 25.
5
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results.根治性膀胱切除术加原位新膀胱用于浸润性膀胱癌:长期肿瘤学、功能和生活质量结果的批判性分析。
World J Urol. 2012 Dec;30(6):725-32. doi: 10.1007/s00345-011-0649-4. Epub 2011 Feb 5.
6
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.淋巴结密度影响根治性膀胱切除术后淋巴结阳性的尿路上皮膀胱癌患者的癌症特异性生存。
Eur Urol. 2011 May;59(5):712-8. doi: 10.1016/j.eururo.2011.01.030. Epub 2011 Jan 28.
7
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.无疾病生存 2 或 3 年与行根治性膀胱切除术的肌层浸润性膀胱癌患者的 5 年总生存相关。
J Urol. 2011 Feb;185(2):456-61. doi: 10.1016/j.juro.2010.09.110. Epub 2010 Dec 17.
8
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.根治性膀胱切除术时的 pT0 期可改善生存:4430 例患者的国际研究。
J Urol. 2010 Sep;184(3):888-94. doi: 10.1016/j.juro.2010.04.081.
9
Female bladder cancer: incidence, treatment, and outcome.女性膀胱癌:发病率、治疗和预后。
Curr Opin Urol. 2010 Sep;20(5):404-8. doi: 10.1097/MOU.0b013e32833c7a9b.
10
Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.与原发性 T1 肿瘤相比,用卡介苗治疗的非原发性 pT1 非肌肉浸润性膀胱癌进展风险更高。
J Urol. 2010 Jul;184(1):81-6. doi: 10.1016/j.juro.2010.03.022. Epub 2010 May 15.